1. Home
  2. BIOX vs PLRX Comparison

BIOX vs PLRX Comparison

Compare BIOX & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bioceres Crop Solutions Corp.

BIOX

Bioceres Crop Solutions Corp.

HOLD

Current Price

$0.59

Market Cap

61.5M

Sector

Industrials

ML Signal

HOLD

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.16

Market Cap

71.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIOX
PLRX
Founded
2001
2015
Country
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.5M
71.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BIOX
PLRX
Price
$0.59
$1.16
Analyst Decision
Buy
Hold
Analyst Count
3
9
Target Price
$4.33
$3.75
AVG Volume (30 Days)
883.2K
896.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$37.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$1.09
52 Week High
$5.40
$3.46

Technical Indicators

Market Signals
Indicator
BIOX
PLRX
Relative Strength Index (RSI) 26.93 42.47
Support Level $0.56 $1.09
Resistance Level $0.63 $1.22
Average True Range (ATR) 0.11 0.06
MACD -0.00 -0.00
Stochastic Oscillator 9.19 29.55

Price Performance

Historical Comparison
BIOX
PLRX

About BIOX Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

Share on Social Networks: